Medicare Enrolled

Dr. Georgia Shapiro, MD

Medical Oncology · Vero Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1500 36TH ST, Vero Beach, FL 32960
7725627777
In practice since 2007 (18 years)
NPI: 1609056308 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shapiro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shapiro? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shapiro

Dr. Georgia Shapiro is a medical oncology in Vero Beach, FL, with 18 years in practice. Based on federal Medicare data, Dr. Shapiro performed 130,868 Medicare services across 4,130 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shapiro received a total of $6,960 from 52 pharmaceutical and/or device companies across 325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shapiro is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 19% volume in FL$ $6,960 industry payments

Medicare Practice Summary

Medicare Utilization ↗
130,868
Medicare services
Top 19% in FL for medical oncology
4,130
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,270 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)79,560$0$2
Denosumab injection (Prolia/Xgeva)19,260$19$33
Epoetin alfa injection (Retacrit) for anemia11,070$6$14
Complete blood count (CBC) with differential4,142$8$43
Dexamethasone injection (steroid)3,218$0$0
Blood draw (venipuncture)3,010$8$16
Anti-nausea injection (ondansetron/Zofran)2,776$0$1
Office visit, established patient (30-39 min)2,456$99$210
Drug injection, under skin or into muscle863$11$31
Anti-nausea injection (Aloxi/palonosetron)664$1$27
Administration of chemotherapy into vein, 1 hour or less493$105$264
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less483$24$68
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle403$59$149
Office visit, established patient, complex (40-54 min)336$141$306
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg287$1$3
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less231$52$134
Administration of additional new drug or substance into vein, 1 hour or less157$53$128
Prothrombin time test (blood clotting)137$4$26
Infusion into a vein for hydration, each additional hour136$11$25
Injection, diphenhydramine hcl, up to 50 mg126$1$2
Manual urinalysis test with examination using microscope, non-automated123$4$25
New patient office visit (45-59 min)115$134$351
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle113$27$57
Infusion, normal saline solution, sterile (500 ml = 1 unit)110$1$2
Administration of chemotherapy into vein, each additional hour95$23$57
Leuprolide acetate (for depot suspension), 7.5 mg84$134$412
Hospital follow-up visit, low complexity82$42$87
Office visit, established patient (20-29 min)72$72$134
Infusion into a vein for hydration, 31-60 minutes55$26$71
Drawing of blood for a medical problem48$76$138
New patient office visit, complex (60-74 min)36$183$424
Irrigation of implanted venous access drug delivery device34$20$52
New patient office visit (30-44 min)22$76$249
Flu vaccine, high-dose19$72$95
Flu vaccine administration19$32$32
Stool analysis for blood to screen for colon tumors18$4$13
Office visit, established patient (10-19 min)15$44$99
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
61.6% high complexity
30.1% medium
8.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,960
Total received (2018-2024)
Avg $994/year across 7 years
Top 50% in FL for medical oncology
52
Companies
325
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,353 (91.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$607 (8.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,079
2023
$2,174
2022
$1,743
2021
$467
2020
$155
2019
$211
2018
$132

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$829
Celgene Corporation
$454
Merck Sharp & Dohme LLC
$452
Astellas Pharma US Inc
$450
AstraZeneca Pharmaceuticals LP
$420
GENZYME CORPORATION
$388
Janssen Biotech, Inc.
$384
Incyte Corporation
$381
Novartis Pharmaceuticals Corporation
$352
Lilly USA, LLC
$291
E.R. Squibb & Sons, L.L.C.
$229
GlaxoSmithKline, LLC.
$202
Regeneron Healthcare Solutions, Inc.
$149
Karyopharm Therapeutics Inc.
$139
ARRAY BIOPHARMA INC
$130
ABBVIE INC.
$130
Seagen Inc.
$119
Bayer Healthcare Pharmaceuticals Inc.
$108
Eisai Inc.
$95
Amgen Inc.
$91
Merck Sharp & Dohme Corporation
$87
PUMA BIOTECHNOLOGY, INC.
$77
SERVIER PHARMACEUTICALS LLC
$66
Pharmacyclics LLC, An AbbVie Company
$62
Foundation Medicine, Inc.
$58
Puma Biotechnology, Inc.
$55
Genentech USA, Inc.
$53
Deciphera Pharmaceuticals Inc.
$48
Pharmacyclics LLC, an AbbVie Company
$46
Pharmacosmos Therapeutics Inc.
$45
JAZZ PHARMACEUTICALS INC.
$43
Taiho Oncology, Inc.
$43
Daiichi Sankyo Inc.
$41
TerSera Therapeutics LLC
$36
Aveo Pharmaceuticals, Inc.
$33
AVEO Pharmaceuticals, Inc.
$30
SOBI, INC
$30
PharmaEssentia USA Corporation
$28
Alnylam Pharmaceuticals Inc.
$27
EMD Serono, Inc.
$27
EISAI INC.
$24
Ipsen Biopharmaceuticals, Inc
$23
Stemline Therapeutics Inc.
$22
Agios Pharmaceuticals, Inc.
$22
Sun Pharmaceutical Industries Inc.
$21
Dendreon Pharmaceuticals LLC
$21
TAIHO ONCOLOGY, INC.
$19
Amneal Pharmaceuticals LLC
$19
AbbVie Inc.
$18
Global Blood Therapeutics, Inc.
$17
RECORDATI_RARE_DISEASES_INC.
$16
Gilead Sciences, Inc.
$12
Top 3 companies account for 24.9% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AVASTIN · BESREMI · BLENREP · BOSULIF · BRAFTOVI · CABLIVI · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ENHERTU · ERLEADA · Enhertu · FOTIVDA · FOUNDATIONONE · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MONJUVI · MONOFERRIC · NERLYNX · Nplate · Nubeqa · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PAXLOVID · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · Padcev · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SYLVANT · Stivarga · TAGRISSO · TASIGNA · TECVAYLI · TUKYSA · Tecentriq · Tibsovo · VENCLEXTA · VERZENIO · VOTRIENT · XALKORI · XPOVIO · XTANDI · Xtandi · YONSA · ZEJULA · ZEPZELCA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $5 per 100 Medicare services performed
Looking for a medical oncology in Vero Beach?
Compare medical oncologys in the Vero Beach area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
3
Per 100K population
1.8
County median income
$71,049
Nearest hospital
CLEVELAND CLINIC INDIAN RIVER HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Shapiro is a mixed practice specialist, with above-average Medicare volume (top 19% in FL), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Shapiro experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Shapiro performed 79,560 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shapiro receive payments from pharmaceutical companies?
Yes. Dr. Shapiro received a total of $6,960 from 52 companies across 325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shapiro's costs compare to other medical oncologys in Vero Beach?
Dr. Shapiro's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shapiro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →